Table 1.
Characteristics of study participants.
| Parameter | |
|---|---|
| N (%) | 390 (100%) |
| Age in years | |
| mean (SD) | 49.6 (12.2) |
| median (IQR) | 53.0 (15) |
| Female gender, n (%) | 179 (45.9%) |
| Lung disease, n (%) | |
| Obstructive | 107 (27.6%) |
| Cystic fibrosis | 104 (26.8%) |
| Restrictive | 111 (28.5%) |
| Other | 68 (17.4%) |
| Listed for transplantation (April 2019) | 262 (67.2%) |
| One-year follow-up available | 109 (27.9%) |
| Oxygen use at rest (L/min) | |
| mean (SD) | 2.4 (1.8) |
| median (IQR) | 2.0 (1.5) |
| GAD-7 | |
| mean (SD) | 3.8 (3.3) |
| median (IQR) | 3.0 (5.0) |
| PHQ-9 | |
| mean (SD) | 6.8 (4.2) |
| median (IQR) | 6.0 (7.0) |
| SF-8, PCS | |
| mean (SD) | 32.7 (7.6) |
| median (IQR) | 32.3 (9.6) |
| SF-8, MCS | |
| mean (SD) | 46.2 (10.9) |
| median (IQR) | 47.0 (16.5) |